James Mulshine to United States Food and Drug Administration
This is a "connection" page, showing publications James Mulshine has written about United States Food and Drug Administration.
Connection Strength
0.073
-
Successful anti-cancer drug targets able to pass FDA review demonstrate the identifiable signature distinct from the signatures of random genes and initially proposed targets. Bioinformatics. 2008 Feb 01; 24(3):389-95.
Score: 0.073